Lucid Diagnostics develops medical diagnostic tools for detecting esophageal precancer before it progresses to cancer, pairing its EsoGuard DNA test with the non-endoscopic EsoCheck cell-collection device. The company’s technology grew from a collaboration with Case Western Reserve University and is processed at Lucid Dx Labs, a CLIA-certified, CAP-accredited laboratory. Lucid also brings its screening directly to at-risk communities through mobile testing units and firefighter screening events.
CLIA Certified
certification
CAP Accredited
certification
Licensed by the New York State Department of Health
registration
FDA 510(k) Clearance for EsoCheck Cell Collection Device
certification
Laboratory Developed Test (LDT)
compliance_program
PAVmed IncCo-founded in 2014 by cardiothoracic surgeons Lishan Aklog and Brian deGuzman alongside medical-device executive Michael Glennon, PAVmed is a diversified, commercial-stage medical technology company built around a shared-services model. Its clinician- and scientist-led teams develop healthcare technologies intended to improve patient care, including Lucid Diagnostics’ EsoGuard test for detecting esophageal precancer and Veris Health’s remote cancer-care platform.HORSHAM, PA
PolymedcoFrom its Cortlandt Manor headquarters, Polymedco develops diagnostic testing systems and screening programs that help healthcare providers detect life-threatening disease earlier. Its portfolio is anchored by OC-Auto FIT, an at-home colorectal cancer screening solution, and PATHFAST, a point-of-care analyzer for urgent cardiac testing. Polymedco stands apart for pairing its diagnostic products with customizable implementation support and clinical education for health systems, laboratories, and emergency departments.CORTLANDT MANOR, NY
UE LifeSciences IncFounded in 2009, UE LifeSciences develops hand-held medical devices and digital tools that make early cancer detection more accessible, starting with its FDA-cleared iBreastExam for quick, painless, radiation-free breast-lump screening. Its Philadelphia-rooted, globally distributed team designs systems for community health workers and has supplied more than 2 million breast exams across 10 markets, with newer tools extending screening to cervical and oral cancer. The company also established an ISO 13485- and WHO-GMP-certified manufacturing facility in India as it expanded internationally.WEST CHESTER, PA
Ultrasonic Medical Mapping, IncBethesda-based Ultrasonic Medical Mapping develops radiation-free cancer-detection technology, adapting a mature method from defense and aerospace testing for medical use. Its patented system is focused on finding pancreatic tumors earlier and at smaller sizes than existing imaging and non-imaging technologies, and the company has built a preclinical prototype for technical validation. UMM is now working toward clinical testing with hospital and clinical partners.BETHESDA, MD